Pfizer (PFE) Dividends payables (QoQ) (2009 - 2021)
Pfizer (PFE) Dividends payables (QoQ) (2009 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.65% |
| Oct 3, 2021 | 0.32% |
| Dec 31, 2020 | 2.37% |
| Sep 27, 2020 | 0.05% |
| Dec 31, 2019 | 5.62% |
| Sep 29, 2019 | 0.05% |
| Dec 31, 2018 | 4.28% |
| Sep 30, 2018 | -0.86% |
| Dec 31, 2017 | 6.29% |
| Oct 1, 2017 | 0.26% |
| Dec 31, 2016 | 6.75% |
| Oct 2, 2016 | 0.05% |
| Jun 29, 2014 | 164,900.00% |
| Mar 30, 2014 | -99.94% |
| Dec 31, 2013 | 166,200.00% |
| Sep 29, 2013 | -99.94% |
| Jun 30, 2013 | 33,600.00% |
| Mar 31, 2013 | -99.71% |
| Dec 31, 2012 | 173,200.00% |
| Sep 30, 2012 | -99.95% |